Abstract
Glycosaminoglycans are found in extracellular matrix and on the cell surface in the form of proteoglycans. There is evidence that these molecules regulate biological processes, including cell survival, migration and angiogenesis. Preeclampsia is a common pregnancy disorder associated with insufficient placental development. This study aimed to determine the concentrations of glycosaminoglycans and the proteoglycan syndecan-1 within villous trophoblast and to investigate changes associated with preeclampsia. Seventy-five placental samples collected from third trimester singleton pregnancies were divided into term placentas following labour onset, gestational age-matched placentas prior to labour onset and preterm placentas. Preterm placentas were divided into three gestational age-matched groups, spontaneous preterm labour, preterm premature rupture of membranes (PPROM) and preterm preeclampsia. Sulphated glycosaminoglycan (sGAG) concentrations in placental extracts were quantified using a modified 1,9-dimethylmethylene blue assay. Syndecan-1 expression was localised using immunohistochemistry and concentrations in placental extracts determined by immunoassay. Preterm placentas had significantly lower sGAG concentrations compared to term tissues and concentrations were significantly lower in preeclampsia compared to spontaneous preterm labour (medians 5.80 and 10.0 μg/mg protein respectively, P<0.05). Syndecan-1 expression was localised to syncytiotrophoblast and median concentrations were lower in preeclampsia compared to PPROM material (preeclampsia median = 41.7, PPROM 74.4 ng/mg tissue) but not significantly different to concentrations in spontaneous preterm labour. Multivariate analysis revealed that decreased sGAG and syndecan-1 in preeclampsia were independent of labour, gestational age and birthweight centile. These findings may provide insights into a role for these molecules in the pathophysiology of preeclampsia.
References
[1] ACOG Committee on Practice Bulletins-Obstetrics. ACOG Practice Bulletin No. 80: premature rupture of membranes. Clinical management guidelines for obstetrician-gynecologists. Obstet Gynecol. 2007;109;1007–19.10.1097/01.AOG.0000263888.69178.1fSearch in Google Scholar
[2] Afratis N, Gialeli C, Nikitovic D, Tsegenidis T, Karousou E, Theocharis AD, et al. Glycosaminoglycans: key players in cancer cell biology and treatment. FEBS J. 2012;279: 1177–97.10.1111/j.1742-4658.2012.08529.xSearch in Google Scholar
[3] Ashikari-Hada S, Habuchi H, Kariya Y, Itoh N, Reddi AH, Kimata K. Characterization of growth factor-binding structures in heparin/heparan sulfate using an octasaccharide library. J Biol Chem. 2004;279:12346–54.10.1074/jbc.M313523200Search in Google Scholar
[4] Ball M, Carmody M, Wynne F, Dockery P, Aigner A, Cameron I, et al. Expression of pleiotrophin and its receptors in human placenta suggests roles in trophoblast life cycle and angiogenesis. Placenta. 2009;30:649–53.10.1016/j.placenta.2009.05.001Search in Google Scholar
[5] Barbosa I, Garcia S, Barbier-Chassefière V, Caruelle JP, Martelly I, Papy-García D. Improved and simple micro assay for sulfated glycosaminoglycans quantification in biological extracts and its use in skin and muscle tissue studies. Glycobiology. 2003;13:647–53.10.1093/glycob/cwg082Search in Google Scholar
[6] Bellamy L, Casas JP, Hingorani AD, Williams DJ. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ. 2007;335:974–85.10.1136/bmj.39335.385301.BESearch in Google Scholar
[7] Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248–54.10.1016/0003-2697(76)90527-3Search in Google Scholar
[8] Brown MA, Lindheimer MD, de Swiet M, Van Assche A, Moutquin JM. The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP) Hypertens Pregnancy. 2001;20:IX–XIV.10.3109/10641950109152635Search in Google Scholar
[9] Cerdeira AS, Karumanchi SA. Angiogenic factors in preeclampsia and related disorders. Cold Spring Harb Perspect Med. 2012;2:a006585.10.1101/cshperspect.a006585Search in Google Scholar PubMed PubMed Central
[10] Chua CC, Rahimi N, Forsten-Williams K, Nugent MA. Heparan sulfate proteoglycans function as receptors for fibroblast growth factor-2 activation of extracellular signal-regulated kinases 1 and 2. Circ Res. 2004;94:316–23.10.1161/01.RES.0000112965.70691.ACSearch in Google Scholar PubMed
[11] Chui A, Murthi P, Brennecke SP, Ignjatovic V, Monagle PT, Said JM. The expression of placental proteoglycans in pre-eclampsia. Gynecol Obstet Invest. 2012;73:277–84.10.1159/000333262Search in Google Scholar
[12] Crescimanno C, Marzioni D, Paradinas FJ, Schrurs B, Mühlhauser J, Todros T, et al. Expression pattern alterations of syndecans and glypican-1 in normal and pathological trophoblast. J Pathol. 1999;189:600–8.10.1002/(SICI)1096-9896(199912)189:4<600::AID-PATH440>3.0.CO;2-QSearch in Google Scholar
[13] Deakin JA, Blaum BS, Gallagher JT, Uhrín D, Lyon M. The binding properties of minimal oligosaccharides reveal a common heparan sulfate/dermatan sulfate-binding site in hepatocyte growth factor/scatter factor that can accommodate a wide variety of sulfation patterns. J Biol Chem. 2009;284:6311–21.10.1074/jbc.M807671200Search in Google Scholar
[14] Fawzy M, Shokeir T, El-Tatongy M, Warda O, El-Refaiey AA, Mosbah A. Treatment options and pregnancy outcome in women with idiopathic recurrent miscarriage: a randomized placebo-controlled study. Arch Gynecol Obstet. 2008;278: 33–8.10.1007/s00404-007-0527-xSearch in Google Scholar
[15] Ferretti C, Bruni L, Dangles-Marie V, Pecking AP, Bellet D. Molecular circuits shared by placental and cancer cells, and their implications in the proliferative, invasive and migratory capacities of trophoblasts. Hum Reprod Update. 2006;13:121–41.10.1093/humupd/dml048Search in Google Scholar
[16] Forsberg E, Pejler G, Ringvall M, Lunderius C, Tomasini-Johansson B, Kusche-Gullberg M, et al. Abnormal mast cells in mice deficient in a heparin-synthesizing enzyme. Nature. 1999;400:773–6.10.1038/23488Search in Google Scholar
[17] Harris LK, Baker PN, Brenchley PE, Aplin JD. Trophoblast-derived heparanase is not required for invasion. Placenta. 2008;29:332–7.10.1016/j.placenta.2008.01.012Search in Google Scholar
[18] Hills FA, Abrahams VM, González-Timón B, Francis J, Cloke B, Hinkson L, et al. Heparin prevents programmed cell death in human trophoblast. Mol Hum Reprod. 2006;12:237–43.10.1093/molehr/gal026Search in Google Scholar
[19] Hills FA, Mehmet H, Sullivan MH. Insulin-like growth factor-II and heparin are anti-apoptotic survival factors in human villous cytotrophoblast. Eur J Obstet Gynecol Reprod Biol. 2012;163:11–6.10.1016/j.ejogrb.2012.03.013Search in Google Scholar
[20] Hjelm AM, Barchan K, Malmström A, Ekman-Ordeberg GE. Changes of the uterine proteoglycan distribution at term pregnancy and during labour. Eur J Obstet Gynecol Reprod Biol. 2002;100:146–51.10.1016/S0301-2115(01)00476-6Search in Google Scholar
[21] Ishihara N, Matsuo H, Murakoshi H, Laoag-Fernandez JB, Samoto T, Maruo T. Increased apoptosis in the syncytiotrophoblast in human term placentas complicated by either preeclampsia or intrauterine growth retardation. Am J Obstet Gynecol. 2002;186:158–66.10.1067/mob.2002.119176Search in Google Scholar PubMed
[22] James JL, Whitley GS, Cartwright JE. Pre-eclampsia: fitting together the placental, immune and cardiovascular pieces. J Pathol. 2010;221:363–78.10.1002/path.2719Search in Google Scholar PubMed
[23] Jokimaa VI, Kujari HP, Ekholm EM, Inki PL, Anttila L. Placental expression of syndecan 1 is diminished in preeclampsia. Am J Obstet Gynecol. 2000;183:1495–8.10.1067/mob.2000.107320Search in Google Scholar PubMed
[24] Kalkunte S, Lai Z, Norris WE, Pietras LA, Tewari N, Boij R, et al. Novel approaches for mechanistic understanding and predicting preeclampsia. J Reprod Immunol. 2009;83:134–8.10.1016/j.jri.2009.08.006Search in Google Scholar PubMed PubMed Central
[25] Khedun SM, Naicker T, Moodley J, Gathiram P. Urinary heparan sulfate proteoglycan excretion in black African women with pre-eclampsia. Acta Obstet Gynecol Scand. 2002;81:308–12.10.1034/j.1600-0412.2002.810405.xSearch in Google Scholar PubMed
[26] Lash GE, Naruse K, Innes BA, Robson SC, Searle RF, Bulmer JN. Secretion of angiogenic growth factors by villous cytotrophoblast and extravillous trophoblast in early human pregnancy. Placenta. 2010;31:545–8.10.1016/j.placenta.2010.02.020Search in Google Scholar PubMed
[27] Lockwood CJ, Oner C, Uz YH, Kayisli UA, Huang SJ, Buchwalder LF, et al. Matrix metalloproteinase 9 (MMP9) expression in preeclamptic decidua and MMP9 induction by tumor necrosis factor alpha and interleukin 1 beta in human first trimester decidual cells. Biol Reprod. 2008;78:1064–72.10.1095/biolreprod.107.063743Search in Google Scholar PubMed PubMed Central
[28] Longtine MS, Chen B, Odibo AO, Zhong Y, Nelson DM. Villous trophoblast apoptosis is elevated and restricted to cytotrophoblasts in pregnancies complicated by preeclampsia, IUGR, or preeclampsia with IUGR. Placenta. 2012;33:352–9.10.1016/j.placenta.2012.01.017Search in Google Scholar PubMed PubMed Central
[29] Lorenzi T, Turi A, Crescimanno C, Morroni M, Castellucci M, David G, et al. Syndecan expressions in the human amnion and chorionic plate. Eur J Histochem. 2010;54:e42.10.4081/ejh.2010.e42Search in Google Scholar PubMed PubMed Central
[30] Louwen F, Muschol-Steinmetz C, Reinhard J, Reitter A, Yuan J. A lesson for cancer research: placental microarray gene analysis in preeclampsia. Oncotarget. 2012;3:759–73.10.18632/oncotarget.595Search in Google Scholar PubMed PubMed Central
[31] Melchiorre K, Wormald B, Leslie K, Bhide A, Thilaganathan B. First-trimester uterine artery Doppler indices in term and preterm pre-eclampsia. Ultrasound Obstet Gynecol. 2008;32:133–7.10.1002/uog.5400Search in Google Scholar PubMed
[32] Mosier PD, Krishnasamy C, Kellogg GE, Desai UR. On the specificity of heparin/heparan sulfate binding to proteins. Anion-binding sites on antithrombin and thrombin are fundamentally different. PLoS One. 2012;7:e48632.10.1371/journal.pone.0048632Search in Google Scholar PubMed PubMed Central
[33] Ogawa M, Yanoma S, Nagashima Y, Okamoto N, Ishikawa H, Haruki A, et al. Paradoxical discrepancy between the serum level and the placental intensity of PP5/TFPI-2 in preeclampsia and/or intrauterine growth restriction: possible interaction and correlation with glypican-3 hold the key. Placenta. 2007;28:224–32.10.1016/j.placenta.2006.01.023Search in Google Scholar PubMed
[34] Prakash GJ, Suman P, Gupta SK. Relevance of syndecan-1 in the trophoblastic BeWo cell syncytialization. Am J Reprod Immunol. 2011;66:385–93.10.1111/j.1600-0897.2011.01017.xSearch in Google Scholar PubMed
[35] Princivalle M, de Agostini A. Developmental roles of heparan sulfate proteoglycans: a comparative review in Drosophila, mouse and human. Int J Dev Biol. 2002;46:267–78.Search in Google Scholar
[36] Rai R, Cohen H, Dave M, Regan L. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). BMJ. 1997;314:253–57.10.1136/bmj.314.7076.253Search in Google Scholar PubMed PubMed Central
[37] Reiland J, Sanderson RD, Waguespack M, Barker SA, Long R, Carson DD, et al. Heparanase degrades syndecan-1 and perlecan heparan sulfate: functional implications for tumor cell invasion. J Biol Chem. 2004;279:8047–55.10.1074/jbc.M304872200Search in Google Scholar PubMed
[38] Santhekadur PK, Gredler R, Chen D, Siddiq A, Shen XN, Das SK, et al. Late SV40 factor (LSF) enhances angiogenesis by transcriptionally up-regulating matrix metalloproteinase-9 (MMP-9). J Biol Chem. 2012;287:3425–32.10.1074/jbc.M111.298976Search in Google Scholar PubMed PubMed Central
[39] Sasisekharan R, Raman R, Prabhakar V. Glycomics approach to structure-function relationships of glycosaminoglycans. Annu Rev Biomed Eng. 2006;8:181–231.10.1146/annurev.bioeng.8.061505.095745Search in Google Scholar PubMed
[40] Sobel ML, Kingdom J, Drewlo S. Angiogenic response of placental villi to heparin. Obstet Gynecol. 2011;117:1375–83.10.1097/AOG.0b013e31821b5384Search in Google Scholar PubMed
[41] Soundararajan R, Rao AJ. Trophoblast’pseudo-tumorigenesis’: significance and contributory factors. Reprod Biol Endocrinol. 2004;2:15.10.1186/1477-7827-2-15Search in Google Scholar PubMed PubMed Central
[42] Stringer SE. The role of heparan sulphate proteoglycans in angiogenesis. Biochem Soc Trans. 2006;34:451–3.10.1042/BST0340451Search in Google Scholar
[43] Taylor KR, Gallo RL. Glycosaminoglycans and their proteoglycans: host-associated molecular patterns for initiation and modulation of inflammation. FASEB J. 2006;20:9–22.10.1096/fj.05-4682revSearch in Google Scholar
[44] Teng YH, Aquino RS, Park PW. Molecular functions of syndecan-1 in disease. Matrix Biol. 2012;31:3–16.10.1016/j.matbio.2011.10.001Search in Google Scholar
[45] Tímár J, Lapis K, Dudás J, Sebestyén A, Kopper L, Kovalszky I. Proteoglycans and tumor progression: Janus-faced molecules with contradictory functions in cancer. Semin Cancer Biol. 2002;12:173–86.10.1016/S1044-579X(02)00021-4Search in Google Scholar
[46] Tkachenko E, Rhodes JM, Simons M. Syndecans: new kids on the signaling block. Circ Res. 2005;96:488–500.10.1161/01.RES.0000159708.71142.c8Search in Google Scholar PubMed
[47] Travis BE, McCullough JM. Pharmacotherapy of preterm labor. Pharmacotherapy. 1993;13:28–36.Search in Google Scholar
[48] Uzun H, Konukoglu D, Albayrak M, Benian A, Madazli R, Aydin S, et al. Increased maternal serum and cord blood fibronectin concentrations in preeclampsia are associated with higher placental hyaluronic acid and hydroxyproline content. Hypertens Pregnancy. 2010;29:153–62.10.3109/10641950902968619Search in Google Scholar PubMed
[49] Wang Y, Zhao S. Cell types of the placenta. In: Vascular biology of the placenta. San Rafael: Morgan and Claypool Life Sciences; 2010.Search in Google Scholar
[50] Warda M, Zhang F, Radwan M, Zhang Z, Kim N, Kim YN, et al. Is human placenta proteoglycan remodeling involved in pre-eclampsia? Glycoconj J. 2008;25:441–50.10.1007/s10719-007-9090-8Search in Google Scholar PubMed PubMed Central
[51] Wasserman L, Shlesinger H, Goldman JA, Allalouf D. Pattern of glycosaminoglycan distribution in tissue and blood vessels of human placenta. Gynecol Obstet Invest. 1983;15:242–50.10.1159/000299416Search in Google Scholar PubMed
[52] Waugh J, Bell SC, Kilby MD, Lambert P, Shennan A, Halligan A. Urine protein estimation in hypertensive pregnancy: which thresholds and laboratory assay best predict clinical outcome? Hypertens Pregnancy. 2005;24:291–302.10.1080/10641950500281019Search in Google Scholar PubMed
[53] Yu H, Chen X. Carbohydrate post-glycosylational modifications. Org Biomol Chem. 2007;5:865–72.10.1039/b700034kSearch in Google Scholar PubMed PubMed Central
[54] Zcharia E, Zilka R, Yaar A, Yacoby-Zeevi O, Zetser A, Metzger S, et al. Heparanase accelerates wound angiogenesis and wound healing in mouse and rat models. FASEB J. 2005;19:211–21.10.1096/fj.04-1970comSearch in Google Scholar
[55] Zhou Y, Bellingard V, Feng KT, McMaster M, Fisher SJ. Human cytotrophoblasts promote endothelial survival and vascular remodeling through secretion of Ang2, PlGF, and VEGF-C. Dev Biol. 2003;263:114–25.10.1016/S0012-1606(03)00449-4Search in Google Scholar
The authors stated that there are no conflicts of interest regarding the publication of this article.
©2014 by Walter de Gruyter Berlin Boston
